Showing 15,821 - 15,840 results of 21,342 for search '(( significantly ((we decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.55s Refine Results
  1. 15821

    Table 1_Longitudinal changes in vitamin D during twin pregnancy: association with maternal–neonatal outcomes.docx by Zhentong Dai (22629206)

    Published 2025
    “…In contrast, chorionicity (p = 0.004), HDP (p = 0.046), and neonatal sex (p = 0.021) were significant determinants of birth weight.</p>Conclusions<p>In twin pregnancies, maintaining adequate VD levels during mid-pregnancy represents a critical preventive window for reducing sPTB. …”
  2. 15822

    Trends in spatial beta diversity over time. by Zoë J. Kitchel (21688386)

    Published 2025
    “…A decrease in dissimilarity represents homogenization (yellow); an increase represents differentiation (pink). …”
  3. 15823

    Model of the consequences of Ctu1 deficiency in zebrafish, figured by Figdraw. by Yangziwei Yu (20460661)

    Published 2024
    “…Inactivation of the CTU complex leads to a thermosensitive decrease with aberrant development in the nematode and fission yeast [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0315854#pone.0315854.ref015" target="_blank">15</a>]. …”
  4. 15824

    Proportion of large and small EEFs over time in the different culture conditions and for each biological replicate. by Erica M. Pasini (3146643)

    Published 2025
    “…Drug-treated <i>P. cynomolgi</i> biological replicates on day 9 show a continued decrease in EEFs. The enrichment in hypnozoites (small EEF) peaks at day 11. …”
  5. 15825

    Data Sheet 1_Development of an LC-MS/MS method for astaxanthin quantification in shrimp tissues and its application to detect astaxanthin variations during ovary development stages... by Shuo Diao (1967698)

    Published 2025
    “…However, a significant redistribution of astaxanthin was observed during the post-developmental stage, characterized by a substantial decrease to 5.74 μg/g in the hepatopancreas, concomitant with an increase to 7.47 μg/g in ovarian tissue.…”
  6. 15826

    Table 1_Examining the mediating function of SIRI in the association between LC9 and chronic obstructive pulmonary disease.docx by Ziming Wang (403663)

    Published 2025
    “…Background<p>Chronic obstructive pulmonary disease (COPD) is a major contributor to early mortality, high overall mortality rates, and significant healthcare costs. …”
  7. 15827

    Table 1_Analysis of the threshold range of ROS concentration in winter rapeseed of the Brassica napus type.docx by Weiliang Qi (9389353)

    Published 2025
    “…<p>The threshold range of reactive oxygen species (ROS) concentration remains a critical challenge and focal point in future research concerning its influence on the growth and development of both beneficial and harmful plants. …”
  8. 15828

    Image 1_Quantitative analysis of targeted lipidomics in the hippocampus of APP/PS1 mice employing the UHPLC-MS/MS method.jpeg by Shiyu Xiao (8147688)

    Published 2025
    “…The levels of some TGs in GLs and CEs in STs showed a significant elevation (p < 0.05, VIP > 1). In contrast, most kinds of MGDGs, HexCers, Cers, PEs and FA (18:2) demonstrated a notable decrease in the hippocampus of AD group (p < 0.05, VIP > 1).…”
  9. 15829

    Image 2_Quantitative analysis of targeted lipidomics in the hippocampus of APP/PS1 mice employing the UHPLC-MS/MS method.jpeg by Shiyu Xiao (8147688)

    Published 2025
    “…The levels of some TGs in GLs and CEs in STs showed a significant elevation (p < 0.05, VIP > 1). In contrast, most kinds of MGDGs, HexCers, Cers, PEs and FA (18:2) demonstrated a notable decrease in the hippocampus of AD group (p < 0.05, VIP > 1).…”
  10. 15830

    Crystal violet assay. by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  11. 15831

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  12. 15832

    Image1_The clinical and genetic aspects of six individuals with GH1 variants and isolated growth hormone deficiency type II.tif by Xiaozhen Huang (5858690)

    Published 2024
    “…Background<p>Isolated growth hormone deficiency type II (IGHD II) is an autosomal dominant disorder characterized by a GH1 gene variant resulting in a significant reduction in growth hormone (GH) secretion and a subsequent decrease of plasma insulin-like growth factor 1 (IGF-1) levels and eventual growth impairment.…”
  13. 15833

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  14. 15834

    FCM analysis (%). by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  15. 15835

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  16. 15836

    Table1_The clinical and genetic aspects of six individuals with GH1 variants and isolated growth hormone deficiency type II.docx by Xiaozhen Huang (5858690)

    Published 2024
    “…Background<p>Isolated growth hormone deficiency type II (IGHD II) is an autosomal dominant disorder characterized by a GH1 gene variant resulting in a significant reduction in growth hormone (GH) secretion and a subsequent decrease of plasma insulin-like growth factor 1 (IGF-1) levels and eventual growth impairment.…”
  17. 15837

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  18. 15838

    Electrophysiological characterization of <i>C. elegans</i> body-wall muscles. by Xuexing Du (20624042)

    Published 2025
    “…The top section of each column illustrates the currents in different mutants, while the bottom section depicts the ionic currents obtained by subtracting the corresponding mutant currents from the total wild type (WT) currents, highlighting a significant decrease in <i>shk-1(lf)</i> and a slight reduction in <i>slo-2(lf)</i> mutants. …”
  19. 15839

    ESR Data for by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”
  20. 15840

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…<div><p>Traditionally, the yeast cell wall (YCW) has limited applications because of its low solubility. To overcome this, a novel method was developed using a hydrothermal reaction to enhance its solubility and decrease its viscosity; this resulted in the production of a soluble form of YCW, known as the YCW treated with hydrothermal reaction (YCW-H), with broader chemical composition. …”